- Home
- WKHS vs RNXT Comparison
WKHS vs RNXT Comparison
Compare WKHS & RNXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WKHS
- RNXT
- Stock Information
- Founded
- WKHS 2007
- RNXT 2012
- Country
- WKHS United States
- RNXT United States
- Employees
- WKHS N/A
- RNXT N/A
- Industry
- WKHS Auto Manufacturing
- RNXT Biotechnology: Pharmaceutical Preparations
- Sector
- WKHS Consumer Discretionary
- RNXT Health Care
- Exchange
- WKHS Nasdaq
- RNXT Nasdaq
- Market Cap
- WKHS 19.5M
- RNXT 21.6M
- IPO Year
- WKHS N/A
- RNXT 2021
- Fundamental
- Price
- WKHS $1.25
- RNXT $1.09
- Analyst Decision
- WKHS Sell
- RNXT Strong Buy
- Analyst Count
- WKHS 4
- RNXT 3
- Target Price
- WKHS $5.42
- RNXT $6.13
- AVG Volume (30 Days)
- WKHS 4.3M
- RNXT 29.4K
- Earning Date
- WKHS 11-14-2024
- RNXT 11-13-2024
- Dividend Yield
- WKHS N/A
- RNXT N/A
- EPS Growth
- WKHS N/A
- RNXT N/A
- EPS
- WKHS N/A
- RNXT N/A
- Revenue
- WKHS $9,616,609.00
- RNXT N/A
- Revenue This Year
- WKHS N/A
- RNXT N/A
- Revenue Next Year
- WKHS $236.05
- RNXT N/A
- P/E Ratio
- WKHS N/A
- RNXT N/A
- Revenue Growth
- WKHS N/A
- RNXT N/A
- 52 Week Low
- WKHS $0.57
- RNXT $0.53
- 52 Week High
- WKHS $8.78
- RNXT $2.35
- Technical
- Relative Strength Index (RSI)
- WKHS 63.95
- RNXT 56.37
- Support Level
- WKHS $0.73
- RNXT $1.04
- Resistance Level
- WKHS $1.94
- RNXT $1.17
- Average True Range (ATR)
- WKHS 0.18
- RNXT 0.08
- MACD
- WKHS 0.06
- RNXT 0.01
- Stochastic Oscillator
- WKHS 42.98
- RNXT 67.86
About WKHS Workhorse Group Inc.
Workhorse Group Inc is a technology company with a vision to pioneer the transition to zero-emission commercial vehicles. Its focus is to provide sustainable and cost-effective solutions to the commercial transportation sector. It designs and manufactures all-electric delivery trucks and drone systems, including the technology that optimizes the way these vehicles operate. It's focused on a core competency of bringing electric delivery vehicle platforms to serve the last-mile delivery market. Its products are marketed under the Workhorse brand.
About RNXT RenovoRx Inc.
RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.